Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +33.64%
#3 Cysic Cysic +15.00%
#4 Fabric Protocol Fabric Protocol +9.87%
#5 Perle Perle +8.90%
#6 Bedrock Bedrock +8.53%
#7 Biconomy Biconomy +4.22%
#8 The Black Bull The Black Bull +3.95%
#9 Cap Cap +3.80%
#10 BOOK OF MEME BOOK OF MEME +3.69%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Rank in Stocks #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Share Price
$0.1
Last synced: 2024-06-18
Market Cap
$1.31M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Pascal Biosciences Inc. (PSCBF)

Category

Healthcare
Number of shares outstanding for Pascal Biosciences Inc. (PSCBF)
Number of shares outstanding as of February 2024: 38.14M
According to Pascal Biosciences Inc. latest financial reports and stock price the company's current number of shares outstanding is 38.14M. At the end of November 2022 the company had 13.11M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Pascal Biosciences Inc. (PSCBF) from 2019 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 38.14M 62.10%
2023 23.53M 79.48%
2022 13.11M 3.25%
2021 12.70M 14.59%
2020 11.08M 5.23%
2019 10.53M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 565.70%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 63.04%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE